Literature DB >> 19572943

The alpha 1B/D-adrenoceptor knockout mouse permits isolation of the vascular alpha 1A-adrenoceptor and elucidates its relationship to the other subtypes.

L Methven1, M McBride, G A Wallace, J C McGrath.   

Abstract

BACKGROUND AND
PURPOSE: Mesenteric and carotid arteries from the alpha(1B/D)-adrenoceptor knockout (alpha(1B/D)-KO) were employed to isolate alpha(1A)-adrenoceptor pharmacology and location and to reveal these features in the wild-type (WT) mouse. EXPERIMENTAL APPROACH: Functional pharmacology by wire myography and receptor localization by confocal microscopy, using the fluorescent alpha(1)-adrenoceptor ligand BODIPY FL-Prazosin (QAPB), on mesenteric (an 'alpha(1A)-adrenoceptor' tissue) and carotid (an 'alpha(1D)-adrenoceptor' tissue) arteries. KEY
RESULTS: Alpha(1B/D)-KO mesenteric arteries showed straightforward alpha(1A)-adrenoceptor agonist/antagonist pharmacology. WT had complex pharmacology with alpha(1A)- and alpha(1D)-adrenoceptor components. alpha(1B/D)-KO had a larger alpha(1A)-adrenoceptor response suggesting compensatory up-regulation: no increase in fluorescent ligand binding suggests up-regulation of signalling. alpha(1B/D)-KO carotid arteries had low efficacy alpha(1A)-adrenoceptor responses. WT had complex pharmacology consistent with co-activation of all three subtypes. Fluorescent binding had straightforward alpha(1A)-adrenoceptor characteristics in both arteries of alpha(1B/D)-KO. Fluorescent binding varied between cells in relative intracellular and surface distribution. Total fluorescence was reduced in the alpha(1B/D)-KO due to fewer smooth muscle cells showing fluorescent binding. WT binding was greater and sensitive to alpha(1A)- and alpha(1D)-adrenoceptor antagonists. CONCLUSIONS AND IMPLICATIONS: The straightforward pharmacology and fluorescent binding in the alpha(1B/D)-KO was used to interpret the properties of the alpha(1A)-adrenoceptor in the WT. Reduced total fluorescence in alpha(1B/D)-KO arteries, despite a clear difference in the functionally dominant subtype, indicates that measurement of receptor protein is unlikely to correlate with function. Fewer cells bound QAPB in the alpha(1B/D)-KO suggesting different cellular phenotypes of alpha(1A)-adrenoceptor exist. The alpha(1B/D)-KO provides robust assays for the alpha(1A)-adrenoceptor and takes us closer to understanding multi-receptor subtype interactions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19572943      PMCID: PMC2795267          DOI: 10.1111/j.1476-5381.2009.00269.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  51 in total

1.  Hypothesis for the initiation of vasomotion.

Authors:  H Peng; V Matchkov; A Ivarsen; C Aalkjaer; H Nilsson
Journal:  Circ Res       Date:  2001-04-27       Impact factor: 17.367

Review 2.  Vascular adrenoceptors: an update.

Authors:  S Guimarães; D Moura
Journal:  Pharmacol Rev       Date:  2001-06       Impact factor: 25.468

3.  Identification of alpha 1L-adrenoceptor in mice and its abolition by alpha 1A-adrenoceptor gene knockout.

Authors:  I Muramatsu; S Morishima; F Suzuki; H Yoshiki; A S M Anisuzzaman; T Tanaka; M C Rodrigo; B E Myagmar; P C Simpson
Journal:  Br J Pharmacol       Date:  2008-09-22       Impact factor: 8.739

4.  The alpha(1D)-adrenergic receptor directly regulates arterial blood pressure via vasoconstriction.

Authors:  Akito Tanoue; Yoshihisa Nasa; Takaaki Koshimizu; Hitomi Shinoura; Sayuri Oshikawa; Takayuki Kawai; Sachie Sunada; Satoshi Takeo; Gozoh Tsujimoto
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

5.  Quantitative imaging in live human cells reveals intracellular alpha(1)-adrenoceptor ligand-binding sites.

Authors:  J F Mackenzie; C J Daly; J D Pediani; J C McGrath
Journal:  J Pharmacol Exp Ther       Date:  2000-08       Impact factor: 4.030

6.  A knockout approach indicates a minor vasoconstrictor role for vascular alpha1B-adrenoceptors in mouse.

Authors:  Craig J Daly; Clare Deighan; Ann McGee; Dawson Mennie; Zeeshan Ali; Melissa McBride; John C McGrath
Journal:  Physiol Genomics       Date:  2002-03-19       Impact factor: 3.107

7.  Differences in the subcellular localization of alpha1-adrenoceptor subtypes can affect the subtype selectivity of drugs in a study with the fluorescent ligand BODIPY FL-prazosin.

Authors:  Tatsuo Sugawara; Akira Hirasawa; Keitaro Hashimoto; Gozoh Tsujimoto
Journal:  Life Sci       Date:  2002-03-22       Impact factor: 5.037

8.  Affinity of serotonin receptor antagonists and agonists to recombinant and native alpha1-adrenoceptor subtypes.

Authors:  R Yoshio; T Taniguchi; H Itoh; I Muramatsu
Journal:  Jpn J Pharmacol       Date:  2001-06

9.  Regulation of the cellular localization and signaling properties of the alpha(1B)- and alpha(1D)-adrenoceptors by agonists and inverse agonists.

Authors:  D F McCune; S E Edelmann; J R Olges; G R Post; B A Waldrop; D J Waugh; D M Perez; M T Piascik
Journal:  Mol Pharmacol       Date:  2000-04       Impact factor: 4.436

10.  Role of the alpha1D-adrenergic receptor in the development of salt-induced hypertension.

Authors:  Akito Tanoue; Masahiro Koba; Shigeki Miyawaki; Taka-aki Koshimizu; Chihiro Hosoda; Sayuri Oshikawa; Gozoh Tsujimoto
Journal:  Hypertension       Date:  2002-07       Impact factor: 10.190

View more
  15 in total

1.  Themed section: Imaging in pharmacology.

Authors:  Anthony P Davenport; Craig Daly
Journal:  Br J Pharmacol       Date:  2010-02       Impact factor: 8.739

2.  GPCR theme editorial.

Authors:  G Milligan; J C McGrath
Journal:  Br J Pharmacol       Date:  2009-09       Impact factor: 8.739

3.  Imaging--the interface with pharmacology: looking to the future.

Authors:  Andrew J Lawrence; Andreas Heinz
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

Review 4.  Localization of α-adrenoceptors: JR Vane Medal Lecture.

Authors:  John C McGrath
Journal:  Br J Pharmacol       Date:  2015-03       Impact factor: 8.739

Review 5.  Updates in the function and regulation of α1 -adrenoceptors.

Authors:  Juliana Akinaga; J Adolfo García-Sáinz; André S Pupo
Journal:  Br J Pharmacol       Date:  2019-04-01       Impact factor: 8.739

6.  Alpha1A/B-knockout mice explain the native alpha1D-adrenoceptor's role in vasoconstriction and show that its location is independent of the other alpha1-subtypes.

Authors:  L Methven; P C Simpson; J C McGrath
Journal:  Br J Pharmacol       Date:  2009-12       Impact factor: 8.739

7.  Removal of half the sympathetic innervation does not reduce vasoconstrictor responses in rat tail artery.

Authors:  Diana Tripovic; Elspeth M McLachlan; James A Brock
Journal:  J Physiol       Date:  2013-04-03       Impact factor: 5.182

8.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

9.  Size-dependent heterogeneity of contractile Ca2+ sensitization in rat arterial smooth muscle.

Authors:  Toshio Kitazawa; Kazuyo Kitazawa
Journal:  J Physiol       Date:  2012-08-28       Impact factor: 5.182

Review 10.  Alpha-1-adrenergic receptors: targets for agonist drugs to treat heart failure.

Authors:  Brian C Jensen; Timothy D O'Connell; Paul C Simpson
Journal:  J Mol Cell Cardiol       Date:  2010-11-28       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.